Browse
Prediction results retrieved after performance evaluation of WHO approved 34 primers to estimate their binding affinities for 3892 SARS-CoV-2 variants.

Lineage
(WHO label)
  
Target Gene
  
Primer Name
  
Primer Sequence
  
Primer Length
  
Primer GC Content (%)
  
Start Position
  
End Position
  
Primer Direction
  
ΔG (cal)
  
Primer first used
  
B.1.160.19EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
B.1.160.12EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
AT.1EWon-ECACACAATCGATGCGCAGTA20502636526346R-463.749South Korea
B.1.619.1EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
P.1.12.1 (Gamma)EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
B.1.160.22EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
AZ.2.1EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
B.1.260EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
B.1.456EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
B.1.160.16EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
AY.4.16 (Delta)EWon-ECACACAATCGATGCGCAGTA20502636526346R-19429.5South Korea
BA.1.22EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
B.1.177.70EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
B.1.177.42EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
B.1.1.428EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
B.1.1.374EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
AY.63 (Delta)EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
B.1.1.377EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
B.1.258.15EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
B.1.1.298EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
C.30.1EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
B.1.177.76EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
B.1.258.11EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
BA.1.2EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
B.1.160.31EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
B.1.1.385EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
B.1.1.384EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
B.1.160.32EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
B.1.1.338EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
BG.6EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
AY.20.1 (Delta)EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
XVEWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
BF.38.2EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
BA.4.1.7EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
BA.2.80EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
AY.134EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
CZ.1EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
BY.1.2.1EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
BM.1.1.2EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
BM.2.3EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
CW.1EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
BA.5.2.42EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
XAY.3EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
CH.3.1EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
XBB.1.46EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
XBC.1.1.1EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
B.1.258.14EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
FL.17.1EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
B.1.177.23EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
B.1.562EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
Lineage
(WHO label)
  
Target Gene
  
Primer Name
  
Primer Sequence
  
Primer Length
  
Primer GC Content (%)
  
Start Position
  
End Position
  
Primer Direction
  
ΔG (cal)
  
Primer first used